QUANTUM-SI INC (QSI)

US74765K1051 - Common Stock

1.62  +0.41 (+33.88%)

After market: 1.66 +0.04 (+2.47%)

Fundamental Rating

3

Overall QSI gets a fundamental rating of 3 out of 10. We evaluated QSI against 55 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for QSI as it has an excellent financial health rating, but there are worries on the profitability. QSI is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year QSI has reported negative net income.
In the past year QSI has reported a negative cash flow from operations.
QSI had negative earnings in each of the past 5 years.
In the past 5 years QSI always reported negative operating cash flow.

1.2 Ratios

QSI has a worse Return On Assets (-38.03%) than 78.18% of its industry peers.
QSI has a Return On Equity of -42.72%. This is in the lower half of the industry: QSI underperforms 65.45% of its industry peers.
Industry RankSector Rank
ROA -38.03%
ROE -42.72%
ROIC N/A
ROA(3y)-28.29%
ROA(5y)N/A
ROE(3y)-30.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 51.54%, QSI is doing good in the industry, outperforming 61.82% of the companies in the same industry.
QSI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

QSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for QSI has been increased compared to 1 year ago.
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

QSI has an Altman-Z score of 0.17. This is a bad value and indicates that QSI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.17, QSI is not doing good in the industry: 65.45% of the companies in the same industry are doing better.
QSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACCN/A
WACC11.28%

2.3 Liquidity

QSI has a Current Ratio of 13.42. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 13.42, QSI belongs to the best of the industry, outperforming 96.36% of the companies in the same industry.
A Quick Ratio of 13.15 indicates that QSI has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 13.15, QSI belongs to the top of the industry, outperforming 96.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.42
Quick Ratio 13.15

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.79% over the past year.
The Revenue has grown by 233.24% in the past year. This is a very strong growth!
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
Revenue 1Y (TTM)233.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%254.26%

3.2 Future

QSI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.16% yearly.
Based on estimates for the next years, QSI will show a very strong growth in Revenue. The Revenue will grow by 160.70% on average per year.
EPS Next Y0.71%
EPS Next 2Y-8.39%
EPS Next 3Y-3.2%
EPS Next 5Y3.16%
Revenue Next Year318.24%
Revenue Next 2Y262.82%
Revenue Next 3Y215.69%
Revenue Next 5Y160.7%

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QSI. In the last year negative earnings were reported.
Also next year QSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as QSI's earnings are expected to decrease with -3.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.39%
EPS Next 3Y-3.2%

0

5. Dividend

5.1 Amount

QSI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

QUANTUM-SI INC

NASDAQ:QSI (11/22/2024, 8:00:58 PM)

After market: 1.66 +0.04 (+2.47%)

1.62

+0.41 (+33.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap231.19M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.03%
ROE -42.72%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 51.54%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 13.42
Quick Ratio 13.15
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y0.71%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)233.24%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y